Sara Melo-Dias
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sara Melo-Dias has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Alda Marques
University of Aveiro
3 shared publications - Ana Sousa
University of Aveiro
2 shared publications - Carla Valente
Ctr Hosp Baixo Vouga, Aveiro, Portugal
2 shared publications - Sara Souto-Miranda
Respiratory Research and Rehabilitation Laboratory (Lab3R), School of Health Sciences (ESSUA), University of Aveiro, Aveiro, Portugal
2 shared publications Alda Marques
Universidade de Aveiro Escola Superior de Saude de Aveiro
1 shared publication- Ana Catarina Silva
UCIBIO, Laboratory of Pharmaceutical Technology, Faculty of Pharmacy, University of Porto, Porto, Portugal
1 shared publication
Latest Publications
- Open Access
Responsiveness to pulmonary rehabilitation in COPD is associated with changes in microbiota
Background: Pulmonary Rehabilitation (PR) is one of the most cost-effective therapies for chronic obstructive pulmonary disease (COPD) management. There are, however, people who do not respond to PR and reasons for non-response are mostly unknown. PR is likely to change the airway microbiota and this could play a role in its responsiveness. In this study we have explored the association between PR effectiveness and specific alterations in oral microbiota and inflammation. Methods: A prospective longitudinal study was conducted. Data on exercise capacity, dyspnoea, impact of disease and 418 saliva samples were collected from 76 patients, half of whom participated in a 12-weeks PR programme. Responders and non-responders to PR (dyspnoea, exercise-capacity and impact of disease) were defined based on minimal clinically important differences. Results: Changes in microbiota, including Prevotella melaninogenica and Streptococcus were observed upon PR. Prevotella , previously found to be depleted in severe COPD, increased during the first month of PR in responders. This increase was negatively correlated with Streptococcus and Lautropia , known to be enriched in severe cases of COPD. Simultaneously, an anti-inflammatory commensal of the respiratory tract, Rothia, correlated strongly and negatively with several pro-inflammatory markers, whose levels were generally boosted by PR. Conversely, in non-responders, the observed decline in Prevotella correlated negatively with Streptococcus and Lautropia whose fluctuations co-occurred with several pro-inflammatory markers. Conclusions: PR is associated with changes in oral microbiota. Specifically, PR increases salivary Prevotella melaninogenica and avoids the decline in Rothia and the increase in Streptococcus and Lautropia in responders, which may contribute to the benefits of PR. Notation of prior abstract publication/presentation: S. Melo-Dias, M. Cabral, A. Furtado, S. Souto-Miranda, J. Cravo, M. A. Mendes, C. R. Almeida, A. Marques, A. Sousa , 2022, “Responsiveness to pulmonary rehabilitation is related with changes in oral microbiota of people with COPD” (Oral communication in 38° Congresso de Pneumologia, November 2022 ) S. Melo-Dias , M. Cabral, A. Furtado, S. Souto-Miranda, J. Cravo, M. A. Mendes, C. R. Almeida, A. Marques, A. Sousa, 2022, “Pulmonary rehabilitation changes the oral microbiota of people with COPD” (Oral communication in ERS International Congress, September 2022 ) S. Melo-Dias , M. Cabral, A. Furtado, S. Souto-Miranda, C. R. Almeida, A. Marques, A. Sousa, 2022, “The Effectiveness of pulmonary rehabilitation in COPD is associated with specific shifts in oral microbiota” (Poster presentation in the 7 th meeting of International Society for Evolution, Medicine and Public Health, July 2022 ) A. Furtado , S. Melo-Dias, M. Cabral, A. Marques, A. Sousa, 2021, “The effect of pulmonary rehabilitation in salivary microbiota of people with chronic obstructive pulmonary disease: A longitudinal study” (Poster presentation in IV International Conference - “Microbiota and Health”, 22 October 2021 )
Open AccessResponsiveness to pulmonary rehabilitation in COPD is associated with changes in microbiota
Background: Pulmonary Rehabilitation (PR) is one of the most cost-effective therapies for chronic obstructive pulmonary disease (COPD) management. There are, however, people who do not respond to PR and reasons for non-response are mostly unknown. PR is likely to change the airway microbiota and this could play a role in its responsiveness. In this study we have explored the association between PR effectiveness and specific alterations in oral microbiota and inflammation. Methods: A prospective longitudinal study was conducted. Data on exercise capacity, dyspnoea, impact of disease and 418 saliva samples were collected from 76 patients, half of whom participated in a 12-weeks PR programme. Responders and non-responders to PR (dyspnoea, exercise-capacity and impact of disease) were defined based on minimal clinically important differences. Results: Changes in microbiota, including Prevotella melaninogenica and Streptococcus were observed upon PR. Prevotella , previously found to be depleted in severe COPD, increased during the first month of PR in responders. This increase was negatively correlated with Streptococcus and Lautropia , known to be enriched in severe cases of COPD. Simultaneously, an anti-inflammatory commensal of the respiratory tract, Rothia, correlated strongly and negatively with several pro-inflammatory markers, whose levels were generally boosted by PR. Conversely, in non-responders, the observed decline in Prevotella correlated negatively with Streptococcus and Lautropia whose fluctuations co-occurred with several pro-inflammatory markers. Conclusions: PR is associated with changes in oral microbiota. Specifically, PR increases salivary Prevotella melaninogenica and avoids the decline in Rothia and the increase in Streptococcus and Lautropia in responders, which may contribute to the benefits of PR. Notation of prior abstract publication/presentation: S. Melo-Dias, M. Cabral, A. Furtado, S. Souto-Miranda, J. Cravo, M. A. Mendes, C. R. Almeida, A. Marques, A. Sousa , 2022, “Responsiveness to pulmonary rehabilitation is related with changes in oral microbiota of people with COPD” (Oral communication in 38° Congresso de Pneumologia, November 2022 ) S. Melo-Dias , M. Cabral, A. Furtado, S. Souto-Miranda, J. Cravo, M. A. Mendes, C. R. Almeida, A. Marques, A. Sousa, 2022, “Pulmonary rehabilitation changes the oral microbiota of people with COPD” (Oral communication in ERS International Congress, September 2022 ) S. Melo-Dias , M. Cabral, A. Furtado, S. Souto-Miranda, C. R. Almeida, A. Marques, A. Sousa, 2022, “The Effectiveness of pulmonary rehabilitation in COPD is associated with specific shifts in oral microbiota” (Poster presentation in the 7 th meeting of International Society for Evolution, Medicine and Public Health, July 2022 ) A. Furtado , S. Melo-Dias, M. Cabral, A. Marques, A. Sousa, 2021, “The effect of pulmonary rehabilitation in salivary microbiota of people with chronic obstructive pulmonary disease: A longitudinal study” (Poster presentation in IV International Conference - “Microbiota and Health”, 22 October 2021 )
- Open Access
- 5 October 2021
- Published by Springer Nature in Research Square
Saliva As A Non-Invasive Specimen For COPD Assessment
Background: People with COPD have been reported to bear a distinct airway microbiota from healthy individuals based on bronchoalveolar lavage (BAL) and sputum samples. Unfortunately, the collection of these samples involves invasive procedures preventing its regular use. Non-invasive samples from the upper airways could constitute an interesting alternative, but its relationship with COPD is still underexplored.We examined the merits of saliva to identify the typical profile of COPD microbiota and test its association with the disease.Methods: Outpatients with COPD and age-sex matched healthy controls were recruited and characterised based on clinical parameters and 16S rRNA profiling of salivary microbiota. A clustering analysis based on patients’ microbiota beta-diversity and logistic regressions were performed to evaluate the association between the microbiota composition and COPD. Results: 128 individuals participated (70 patients and 58 controls). Differential abundance analyses showed differences in patients comparable to the ones previously observed in samples from the lower respiratory tract, i.e., an increase in Proteobacteria (particularly Haemophilus) and loss of microbiota diversity. An unsupervised clustering analysis separated patients in two groups based on microbiota composition differing significantly in the frequency of patients hospitalized due to severe acute exacerbation of COPD (AECOPD) and in the frequency of GOLD D patients. Furthermore, a low frequency of Prevotella was associated with a significantly higher risk of recent severe AECOPD and of being GOLD D.Conclusion: Salivary microbiota showed an association with COPD, particularly with severe exacerbations, supporting the use of this non-invasive specimen for future studies of heterogeneous respiratory diseases like COPD.
- 5 October 2021
- Published by Springer Nature in Research Square
Open AccessSaliva As A Non-Invasive Specimen For COPD Assessment
Background: People with COPD have been reported to bear a distinct airway microbiota from healthy individuals based on bronchoalveolar lavage (BAL) and sputum samples. Unfortunately, the collection of these samples involves invasive procedures preventing its regular use. Non-invasive samples from the upper airways could constitute an interesting alternative, but its relationship with COPD is still underexplored.We examined the merits of saliva to identify the typical profile of COPD microbiota and test its association with the disease.Methods: Outpatients with COPD and age-sex matched healthy controls were recruited and characterised based on clinical parameters and 16S rRNA profiling of salivary microbiota. A clustering analysis based on patients’ microbiota beta-diversity and logistic regressions were performed to evaluate the association between the microbiota composition and COPD. Results: 128 individuals participated (70 patients and 58 controls). Differential abundance analyses showed differences in patients comparable to the ones previously observed in samples from the lower respiratory tract, i.e., an increase in Proteobacteria (particularly Haemophilus) and loss of microbiota diversity. An unsupervised clustering analysis separated patients in two groups based on microbiota composition differing significantly in the frequency of patients hospitalized due to severe acute exacerbation of COPD (AECOPD) and in the frequency of GOLD D patients. Furthermore, a low frequency of Prevotella was associated with a significantly higher risk of recent severe AECOPD and of being GOLD D.Conclusion: Salivary microbiota showed an association with COPD, particularly with severe exacerbations, supporting the use of this non-invasive specimen for future studies of heterogeneous respiratory diseases like COPD.
- Open Access
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64) , 77
Patients’ perspectives on exposure to environmental contaminants: a missing piece in pulmonary rehabilitation?
Chronic obstructive pulmonary disease (COPD) is influenced by environmental factors, such as indoor/outdoor contaminants. However, patients’ views on environmental exposure are little-known and this is an often-neglected topic in psychoeducational sessions in pulmonary rehabilitation (PR). We explored the views of patients with COPD about indoor/outdoor environment and its influence on their health and the impact of an environmental educational session within PR, on their daily living. Focus groups were conducted before and after community-based PR. An educational session was designed and included in PR after the first focus group. Data were analysed with thematic analysis. Four focus groups were conducted with 31 patients with COPD (71±8y; 74%male; FEV1 48±17pp; 45% GOLD2; 58% GOLDB). Prior to PR, 3 themes emerged: 1) “just seeing the tip of the iceberg” since some awareness existed but a feeling of probably not knowing the real impact was shared; 2) “feeling resigned” where patients acknowledged having poor strategies to avoid contaminants and felt there was little they could do; and 3) “willingness to learn” as they reported the need for an educational session to improve their knowledge on environmental exposures. After PR, 2 themes were found: 1) “gratefulness” where patients shared that the session was helpful for themselves and significant others; and 2) “personal change”, where patients expressed how their behaviour changed towards more health-enhancing strategies to deal with contaminants. Environmental education within PR is valued by patients and leads to specific behaviour changes to deal with contaminants’ exposure. Further attention to this topic is warranted.
- 7 September 2020
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 56 (suppl 64) , 77
Open AccessPatients’ perspectives on exposure to environmental contaminants: a missing piece in pulmonary rehabilitation?
Chronic obstructive pulmonary disease (COPD) is influenced by environmental factors, such as indoor/outdoor contaminants. However, patients’ views on environmental exposure are little-known and this is an often-neglected topic in psychoeducational sessions in pulmonary rehabilitation (PR). We explored the views of patients with COPD about indoor/outdoor environment and its influence on their health and the impact of an environmental educational session within PR, on their daily living. Focus groups were conducted before and after community-based PR. An educational session was designed and included in PR after the first focus group. Data were analysed with thematic analysis. Four focus groups were conducted with 31 patients with COPD (71±8y; 74%male; FEV1 48±17pp; 45% GOLD2; 58% GOLDB). Prior to PR, 3 themes emerged: 1) “just seeing the tip of the iceberg” since some awareness existed but a feeling of probably not knowing the real impact was shared; 2) “feeling resigned” where patients acknowledged having poor strategies to avoid contaminants and felt there was little they could do; and 3) “willingness to learn” as they reported the need for an educational session to improve their knowledge on environmental exposures. After PR, 2 themes were found: 1) “gratefulness” where patients shared that the session was helpful for themselves and significant others; and 2) “personal change”, where patients expressed how their behaviour changed towards more health-enhancing strategies to deal with contaminants. Environmental education within PR is valued by patients and leads to specific behaviour changes to deal with contaminants’ exposure. Further attention to this topic is warranted.
- 7 March 2019
- Published by European Respiratory Society (ERS)
- Vol. 5 (suppl 2) , PP224
Airway Microbiota diversity and composition correlates with severity of Chronic Obstructive Pulmonary Disease (COPD)
COPD occurrence is mediated by immune response, environmental factors and microbial dysbiosis. Airway microbiota has been found to be different between healthy people and patients with COPD and these differences could influence disease severity. But, its clinical implications are still unclear. Here, we have explored the airway microbiota of patients with COPD as well as its relations with specific clinical parameters. 40 patients (35?, 67±9y, FEV1pp 33±7, GOLD III-26, IV-14) and 40 healthy controls (34?, 67±12y, FEV1pp 101±19) were recruited and sociodemographic, anthropometric and clinical data were collected. Saliva microbiota was characterised by 16S rRNA sequencing and analysed using Qiime2 pipeline. Significant differences in airway microbiota composition between patients and healthy people were observed (Fig 1). The microbiota of patients with worse clinical parameters, like lower FEV1pp and SpO2, or with higher number of exacerbations and hospitalisations, clustered separately from less severe. Loss of microbiota diversity correlated with age in patients, but not in healthy people, raising the hypothesis of the cumulative use of antibiotics (by patients) contributing to dysbiosis. The association between microbiota composition and clinical parameters supports its contribution to COPD trajectory. Future studies should focus on remodelling patients’ dysbiotic microbiotas towards healthier ensembles aiming at preventing disease decline.
- 7 March 2019
- Published by European Respiratory Society (ERS)
- Vol. 5 (suppl 2) , PP224
Airway Microbiota diversity and composition correlates with severity of Chronic Obstructive Pulmonary Disease (COPD)
COPD occurrence is mediated by immune response, environmental factors and microbial dysbiosis. Airway microbiota has been found to be different between healthy people and patients with COPD and these differences could influence disease severity. But, its clinical implications are still unclear. Here, we have explored the airway microbiota of patients with COPD as well as its relations with specific clinical parameters. 40 patients (35?, 67±9y, FEV1pp 33±7, GOLD III-26, IV-14) and 40 healthy controls (34?, 67±12y, FEV1pp 101±19) were recruited and sociodemographic, anthropometric and clinical data were collected. Saliva microbiota was characterised by 16S rRNA sequencing and analysed using Qiime2 pipeline. Significant differences in airway microbiota composition between patients and healthy people were observed (Fig 1). The microbiota of patients with worse clinical parameters, like lower FEV1pp and SpO2, or with higher number of exacerbations and hospitalisations, clustered separately from less severe. Loss of microbiota diversity correlated with age in patients, but not in healthy people, raising the hypothesis of the cumulative use of antibiotics (by patients) contributing to dysbiosis. The association between microbiota composition and clinical parameters supports its contribution to COPD trajectory. Future studies should focus on remodelling patients’ dysbiotic microbiotas towards healthier ensembles aiming at preventing disease decline.